Mangalam Drugs and Organics Ltd
As of 20 Nov 2026, Mangalam Drugs and Organics is in Stage 3, the topping phase, now in its first week (since 20 Nov 2026). It closed at ₹27.55, 55.8% below its 52-week high and below its 200-day average, which is falling. In Health Care, 34.7% of stocks are in Stage 2.
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. More about the company
Pro read
ProMANGALAM's uptrend is tiring: in its first week into a top. A topping stock either breaks back out or rolls over into a decline, and the next few weeks usually settle which.
Its relative strength is 4 of 99, below the middle among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.
Is MANGALAM early, or has it already run? Pro answers that for every NSE stock, after every close.
MANGALAM among Pharmaceuticals110th of 118 by relative strength
All 118 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BLISSGVS | Stage 2 · wk 49 | 99 | +4.6% |
| 2 | KPL | Stage 2 · wk 44 | 99 | +20.5% |
| 3 | FREDUN | Stage 2 · wk 33 | 98 | +24.0% |
| 4 | VENUSREM | Stage 3 · wk 10 | 98 | −1.5% |
| 5 | RUBICON | Stage 3 · wk 4 | 98 | +18.7% |
| 6 | SAKAR | Stage 2 · wk 55 | 98 | +13.1% |
| 7 | BAFNAPH | Stage 2 · wk 23 | 98 | +1.9% |
| 8 | INDSWFTLAB | Stage 2 · wk 23 | 98 | −7.4% |
| …110 | MANGALAM | Stage 3 · wk 1 | 4 | −9.4% |
Mangalam Drugs and Organics: quick answers
What stage is Mangalam Drugs and Organics in?
As of 20 Nov 2026, Mangalam Drugs and Organics (MANGALAM) is in Stage 3, the topping phase. It entered Stage 3 on 20 Nov 2026 and is in its first week there. What the four stages mean
Is Mangalam Drugs and Organics in an uptrend?
Its uptrend has stalled. Mangalam Drugs and Organics is in Stage 3, the topping phase that follows an advance. It trades 8.0% below its 200-day average, which is falling.
How far is Mangalam Drugs and Organics from its 52-week high?
Mangalam Drugs and Organics closed at ₹27.55 on 20 Nov 2026, 55.8% below its 52-week high of ₹62.30. Its 52-week low is ₹23.78.
How has Mangalam Drugs and Organics performed over the past year?
As of 20 Nov 2026, Mangalam Drugs and Organics is down 55.5% over the past year and up 0.1% so far in 2026.
Which sector and industry is Mangalam Drugs and Organics in?
Mangalam Drugs and Organics is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals
About this companyHealth Care· Pharmaceuticals
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. Additionally, it offers active pharmaceutical ingredients; and products covering various therapeutic areas comprising anti-malaria, anti-retroviral, anti-hypertensive, anti-inflammatory, anti-convulsant, anti-viral, anti-rheumatic arthritis agents, and anti-bacterial, as well as develops product for anti-hypertensive indications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.